ArticleCancers2022

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.

Takuya Sho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.